<table id="_Refid_a7df07ad-6aee-4a47-9bc4-943cf567b" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="32%"></col>
<col width="32%"></col>
<col width="37%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule " valign="bottom">
<paragraph>Concomitant Drug</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule " valign="bottom">
<paragraph>Effect on Concentration of Lamotrigine or Concomitant Drug</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule " valign="bottom">
<paragraph>Clinical Comment</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and <br/>150 mcg levonorgestrel</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Decreased lamotrigine levels approximately 50%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>↓ levonorgestrel</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>Carbamazepine (CBZ) and CBZ epoxide</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>? CBZ epoxide</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>May increase CBZ epoxide levels.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Phenobarbital/Primidone</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Phenytoin (PHT)</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Rifampin</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine AUC approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td rowspan="2" stylecode="Rrule Lrule Botrule ">
<paragraph>Valproate</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↑ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Increased lamotrigine concentrations slightly more than 2-fold. <br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>? valproate</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients.</paragraph>
</td>
</tr>
<tr>
<td colspan="3" stylecode="Rrule Botrule Lrule ">
<paragraph>↓= Decreased (induces lamotrigine glucuronidation). </paragraph>
<paragraph>↑= Increased (inhibits lamotrigine glucuronidation). </paragraph>
<paragraph>?= Conflicting data. </paragraph>
</td>
</tr>
</tbody>
</table>